sb 202190 has been researched along with Vitreoretinopathy, Proliferative in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Vitreoretinopathy, Proliferative: Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saika, S | 1 |
| Yamanaka, O | 1 |
| Ikeda, K | 1 |
| Kim-Mitsuyama, S | 1 |
| Flanders, KC | 1 |
| Yoo, J | 1 |
| Roberts, AB | 1 |
| Nishikawa-Ishida, I | 1 |
| Ohnishi, Y | 1 |
| Muragaki, Y | 1 |
| Ooshima, A | 1 |
1 other study available for sb 202190 and Vitreoretinopathy, Proliferative
| Article | Year |
|---|---|
Inhibition of p38MAP kinase suppresses fibrotic reaction of retinal pigment epithelial cells.
Topics: Animals; Cell Line; Cell Movement; Cell Proliferation; Collagen Type I; Disease Models, Animal; Enzy | 2005 |